Chronic Obstructive Pulmonary Disease

Slides:



Advertisements
Similar presentations
GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Advertisements

Role of anticholinergic therapy in COPD Adil Al Sulami Medical Resident KAUH.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 32 Bronchodilator Drugs and the Treatment of Asthma.
Michael W. Nash, MD Family Medicine Clinton County Rural Health Clinic Understanding COPD.
Chronic Obstructive Pulmonary Disease (COPD). COPD is characterized by : **Chronic airflow obstruction & accelerated loss of lung function which is progressive.
Phamacology Final Exam Review.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE Treatment Opportunities in a Heartsink Disease Jim Reid.
Management of COPD & Asthma Melissa Brittle & Jessica Macaro.
COPD (Chronic Obstructive Pulmonary Disease)
Drugs For Treating Asthma
COPD: MANAGEMENT OF STABLE DISEASE AND EXACERBATIONS Dennis E. Doherty, M.D. Professor of Medicine Chief, Division of Pulmonary and Critical Care Medicine.
COPD MANAGEMENT FALLS SHORT AT RCRMC Jean Solomon, M.D.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE CLINICAL PRACTICE GUIDELINES REVIEW WEEK 2: THERAPY AMBULATORY INTERNAL MEDICINE GROUP PRACTICE UNIVERSITY HEALTH.
Chronic obstructive pulmonary disease (COPD) Professor Bill MacNee
Respiratory drugs -Surag Khadka. Learning outcomes Classes of drugs MoA of the following Beta-2 agonists Anti-cholinergics Leukotriene antagonists Methylxanthines.
COPD Management of Stable COPD Shyam Rao May 2014.
Faculty Research Advisor: Dr. David Blake. Background Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 76 Drugs for Asthma.
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 7 Anticholinergic (Parasympatholytic) Bronchodilators.
Management of Chronic Airflow Obstruction J.R. Sheller, M.D. Allergy, Pulmonary & Critical Care Medicine.
Chronic Obstructive Pulmonary Disease. Why COPD is Important ? COPD is the only chronic disease that is showing progressive upward trend in both mortality.
Chronic Obstructive Pulmonary Disease (COPD)
Bronchial Asthma  Definition  Patho-physiology  Diagnosis  Management.
 Definition  Asthma is a chronic inflammatory disorder of the lung airways, characterised by reversible airway obstruction, airway hyper-responsiveness,
Anticholinergics in COPD presented by: Soha Ragab Moselhy group 2.
1 DRUGS AFFECTING RESPIRATORY SYSTEM. 2 ASTHMA chronic inflammatory airway disease excessive tracheobronchial reactivity SYMPTOMS wheezing, chest tightness,
COPD – PBL 8. Hypercapnia (  CO 2 )Hypoxia (  O 2 ) HyperventilationDyspnoea AsterixisHeadaches/fatigue Flushed skinCynosis Disturbed sleepTachapneoa.
A Concise Workup of COPD E. James Britt, MD Common diseases are common 3rd leading cause of mortality COPD is overlooked Women > men but underdiagnosed.
Definition COPD def- A disease state characterized by air flow limitation that is not fully reversible It is expected to be the 3 rd leading cause of.
Chapter 9 Respiratory System Drugs Copyright © 2011 Delmar, Cengage Learning.
Andriy Lepyavko, MD, PhD Department of Internal Medicine № 2.
Copyright © 2012, 2008, 2002, 1998, 1994, 1989, 1984, 1978 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 7 Anticholinergic (Parasympatholytic)
Bronchodilators and Other Respiratory Agents. Asthma -Predominantly in boys 2:1 -puberty: occurrence equals out -More females in adult-onset cases -Affects.
Home Care of Chronic Obstructive Pulmonary Disease Patients.
PHARMACOTHERAPY OF RESPIRATORY DISEASES. Bronchial asthma Bronchial asthma is a disease caused by increased responsiveness of the tracheobronchial tree.
Disorders of the Respiratory System By : Amir Ashkan Ashrafian M.D.
Andriy Lepyavko, MD, PhD Department of Internal Medicine № 2.
Bronchodilators and Other Respiratory Agents
Clinical pharmacology of drugs acting on the respiratory organs function.
Drugs. Thyroid Medications Synthroid -Levothyroxine Indications – Hypothryroidism Armour Thyroid – Hypothyroidism.
Long Term Effects Of Tobacco Use TSWBBAT Describe how tobacco use affects the body systems -short term and long term.
Management Of Exacerbations Of Chronic Obstructive Pulmonary Disease D.Anan Esmail Seminar Training Primary Care Asthma + COPD
LSU Journal Club Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD WISDOM study H. Magnussen MD, et al. Nisha Loganantharaj, PGY1 April 21,
СOPD Chronic obstructive pulmonary disease (COPD), a common preventable and treatable disease, is characterized by persistent airflow limitation that.
β2 Agonists Albuterol and other inhaled short-acting selective β2 agonists are indicated for treatment of intermittent episodes of bronchospasm and are.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
Respiratory Health Asthma and COPD. Definition of asthma 2 Working definition by AAH 2014: Chronic lung disease Can be controlled not cured Large variation.
Pharmacology of Anti- Asthmatic Medications
Eileen G. Holland, Pharm.D., BCPS Associate Professor
Management of Chronic Airflow Obstruction
Respiratory System Diseases and Management Part IV
COPD Tutoring – Part 2 By Alaina Darby.
The Respiratory System
UNIT 8: DRUGS USED IN THE TREATMENT OF RESPIRATORY DISORDERS
RESPIRATORY PHARMACOLOGY
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD)
DRUGS AFFECTING THE RESPIRATORY SYSTEM
Chapter 32 Airway Pharmacology
Mean changes in the Short Form-36 subscales from baseline values for combined pulmonary fibrosis and emphysema (CPFE) (n=16), and chronic obstructive pulmonary.
Drugs Affecting the Respiratory System
Pharmacology of drugs used in bronchial asthma & COPD
Chronic Obstructive Pulmonary Disease
Inhaled bronchodilators in maintenance treatment of chronic obstructive pulmonary disease; historical evolution along the lines of evidence. Inhaled bronchodilators.
William P. Saliski Jr. DO Montgomery Pulmonary Consultants
Respiratory Unit Questions
Changes in 6 min walk distance (6MWD) for combined pulmonary fibrosis and emphysema (CPFE) (n=15), and chronic obstructive pulmonary disease (COPD) (n=37).
Where Does Anticholinergic Therapy Fit in Moderate to Severe Asthma?
Generic COPD Inhalers Online
Presentation transcript:

Chronic Obstructive Pulmonary Disease Presented by Muhammad Shamim

Defining COPD

CB Emphysema

What happens in asthma?

COPD and Asthma

Airflow Limitation in COPD

Pharmacotherapy Short-acting inhaled beta-2 agonists (example albuterol) Long-acting beta-2 agonists (example salmeterol) Short-acting inhaled anticholinergic agents (example ipratropium) Long acting anticholinergic agents (example tiotropium) Combination agents (example Combivent) Systemic bronchodilators (example Theophylline) Glucocorticoids (example prednisone, fluticasone)

QUESTIONS?? Or Comments

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.